No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs4461048 |
chr15:39048231-39048232 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs77253678 |
chr15:39048274-39048275 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs538537510 |
chr15:39048311-39048312 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs2912371 |
chr15:39048325-39048326 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs115210350 |
chr15:39048336-39048337 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs543747666 |
chr15:39048365-39048366 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs367838915 |
chr15:39048368-39048369 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs371623961 |
chr15:39048380-39048381 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs8033016 |
chr15:39048381-39048382 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs8038263 |
chr15:39048396-39048397 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs537100023 |
chr15:39048428-39048429 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs59320522 |
chr15:39048498-39048499 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
13 |
rs149825643 |
chr15:39048507-39048508 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs61415249 |
chr15:39048518-39048519 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
15 |
rs2958268 |
chr15:39048533-39048534 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
16 |
rs576228323 |
chr15:39048541-39048542 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs8037289 |
chr15:39048558-39048559 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs74318753 |
chr15:39048567-39048568 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs61557749 |
chr15:39048606-39048607 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
20 |
rs573529145 |
chr15:39048638-39048639 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs529827906 |
chr15:39048642-39048643 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs144770856 |
chr15:39048652-39048653 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs187647295 |
chr15:39048653-39048654 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs551045179 |
chr15:39048659-39048660 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs563320744 |
chr15:39048660-39048661 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs547833129 |
chr15:39048662-39048663 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs139767181 |
chr15:39048692-39048693 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs144538960 |
chr15:39048719-39048720 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs140647541 |
chr15:39048737-39048738 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs568664948 |
chr15:39048747-39048748 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs397811895 |
chr15:39048749-39048750 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs35732613 |
chr15:39048750-39048751 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs140843995 |
chr15:39048792-39048793 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs193090427 |
chr15:39048798-39048799 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs565993112 |
chr15:39048800-39048801 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs28527363 |
chr15:39048907-39048908 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs80084958 |
chr15:39048913-39048914 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs550632686 |
chr15:39048914-39048915 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs184154788 |
chr15:39048918-39048919 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs374172835 |
chr15:39048950-39048951 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs187557000 |
chr15:39049005-39049006 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs552871236 |
chr15:39049086-39049087 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs202128740 |
chr15:39049090-39049091 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs397817180 |
chr15:39049092-39049093 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs540787357 |
chr15:39049098-39049099 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs552754767 |
chr15:39049118-39049119 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs527941543 |
chr15:39049137-39049138 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs2929654 |
chr15:39049241-39049242 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs563124867 |
chr15:39049278-39049279 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs371743460 |
chr15:39049304-39049305 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|